Skip to main content
Premium Trial:

Request an Annual Quote

Synthetic Genomics Acquires IP from Febit

NEW YORK (GenomeWeb News) – Synthetic Genomics today announced its acquisition of the worldwide rights to three families of patents and patent applications related to synthetic genomic technologies from Germany's Febit Holding.

Included in the deal are related know-how, equipment, and technical support for implementation, La Jolla, Calif.-based Synthetic Genomics said. Financial terms of the transaction were not disclosed.

The acquired IP includes seven patents issued in the US and Europe covering methods to produce polymers and methods for retrieving sequence-verified synthetic nucleic acids after they've been assembled on solid supports. The methods can be used for synthesizing genetic components in parallel and then selectively assembling the components that have the perfect sequence into double stranded genes and larger DNA constructs with minimal errors, Synthetic Genomics said.

The technologies, it added, could "drastically" lower the cost of DNA synthesis, a hindrance to the synthetic biology community since the first synthetic gene was produced four decades ago, the company said.

Synthetic Genomics Founder and CEO J. Craig Venter said in a statement that the purchased IP "will strengthen and accelerate SGI's ongoing development and commercialization of a variety of products including algae-based food and nutritional products, biofuels, biochemicals, synthetic vaccines, and clean water.

"The ability to construct accurate and inexpensive DNA, together with our current proprietary DNA assembly and genome transplantation methodologies, enable enhanced capacity to synthesize DNA and reprogram cells at a larger scale than what is currently achievable," he added.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.